CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Meta Platforms, Inc.

META
$1.60T
Mega Cap
NASDAQServices-Computer Programming, Data Processing, Etc.Social media🇺🇸North AmericaMENLO PARK78.0K employees

Meta Platforms, Inc. (doing business as Meta) is an American multinational technology company headquartered in Menlo Park, California. Meta owns and operates several prominent social media platforms and communication services, including Facebook, Instagram, WhatsApp, Messenger, and Threads. The company also operates an advertising network for its own sites and third parties; as of 2023, advertising accounted for 97.8 percent of its total revenue. Meta has been described as a part of Big Tech, which refers to the largest six tech companies in the United States, Alphabet (Google), Amazon, Apple, Meta (Facebook), Microsoft, and Nvidia, which are also the largest companies in the world by market capitalization.

Website

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

META News
Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How META's past catalysts played out

Drug Pipeline

No drugs found in this phase.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is Meta Platforms, Inc.'s next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for Meta Platforms, Inc. (META) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track META biotech catalysts?

Add META to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Meta Platforms, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply